Quest Diagnostics (NYSE: DGX)
Quality Value Investing Research Report | Updated Coverage | October 2025
Summary
In this updated QVI Research Report, we reexamine the QVI Real-Time Stock Picks health care sector holding Quest Diagnostics Inc. (NYSE: DGX) to see if it continues to meet Quality Value Investing’s investment criteria based on our checklist analysis of the business’s current wealth and its stock’s present value.
We’ll analyze the company’s value proposition, management’s returns, enterprise downside risks, and the stock’s shareholder yields, valuation, and share price downside risks, ending with an actionable investment thesis.
Quality Value Investing’s Research Checklist items included in the report:
Quest Diagnostics | Company Current Wealth
Value Proposition
Returns on Management
Enterprise Downside Risks
DGX | Stock Price Present Value
Shareholder Yields
Valuation Multiples
Share Price Downside Risks
Quest Diagnostics + DGX Investment Thesis
Current Wealth and Present Value Ratings Recap
QVI updated investment call
Catalysts (bulls say / bears say)
Subscriber Resources
Click below to read or listen to how DGX, as a component of the QVI Real-time Stock Picks, has performed in relation to the S&P 500 benchmark since Quality Value Investing began coverage in early 2022, as well as the company’s prospects and standing within the QVI Picks.
https://davidjwaldron.substack.com/p/quest-diagnostics-nyse-dgx-eb6